| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |